Rubric Capital Management (New York)’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.7M | Buy |
8,531,860
+3,993,325
| +88% | +$21.8M | 0.71% | 33 |
|
|
2025
Q1 | $28.5M | Buy |
4,538,535
+333,406
| +8% | +$2.1M | 0.51% | 40 |
|
|
2024
Q4 | $17.3M | Sell |
4,205,129
-821,802
| -16% | -$3.39M | 0.22% | 48 |
|
|
2024
Q3 | $16.8M | Hold |
5,026,931
| – | – | 0.27% | 47 |
|
|
2024
Q2 | $15M | Sell |
5,026,931
-537,192
| -10% | -$1.6M | 0.39% | 49 |
|
|
2024
Q1 | $19.2M | Sell |
5,564,123
-120,297
| -2% | -$415K | 0.57% | 48 |
|
|
2023
Q4 | $7.62M | Hold |
5,684,420
| – | – | 0.16% | 47 |
|
|
2023
Q3 | $12.4M | Hold |
5,684,420
| – | – | 0.46% | 45 |
|
|
2023
Q2 | $13.6M | Hold |
5,684,420
| – | – | 0.58% | 42 |
|
|
2023
Q1 | $10.5M | Hold |
5,684,420
| – | – | 0.27% | 53 |
|
|
2022
Q4 | $11M | Hold |
5,684,420
| – | – | 0.48% | 53 |
|
|
2022
Q3 | $8.75M | Buy |
5,684,420
+3,906,000
| +220% | +$6.02M | 0.44% | 49 |
|
|
2022
Q2 | $5M | Buy |
+1,778,420
| New | +$5M | 0.26% | 61 |
|